August J. Troendle (CEO & Chairman of the Board of Directors)
Products
Support services for pharmaceutical, biotech, and medical device companies
Revenue
US$1.46 billion (2022)[1]
Number of employees
5,400 (2023)[1]
Website
medpace.com
Medpace Holdings, Inc. (alt. Medpace) is a global clinical research organization (CRO) based in Cincinnati, Ohio,[2][1][3] employing approximately 5,400 people. Medpace's mission statement is "to accelerate the global development of safe and effective medical therapeutics" through its high science and disciplined operating approach that leverages local, regulatory, and deep therapeutic expertise across all major areas, including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective. Operating under a full-service model, Medpace provides a therapeutically focused, integrated, global approach to clinical development. The company also offers global central laboratory, imaging core laboratory, and bioanalytical laboratory services, as well as a Phase I unit located on its headquarters and clinical research campus in Cincinnati, Ohio.
The company started trading stock as a public firm in 2016.
^ abcdAycock, Jason (24 June 2016). "Medpace Holdings files to raise up to $150M in IPO". Seeking Alpha. Retrieved 2016-06-26.
^Vinluan, Frank (14 June 2011). "Mid-sized CROs perform as good or better than larger ones, survey says". MedCity News. New York, New York: Breaking Media. Retrieved 31 Aug 2019. The strong performance of mid-sized CROs was evident in the category for speed of site and investigator recruitment. Cincinnati, Ohio-based MedPace was the highest scoring CRO in survey responses for that category while large CROs such as Covance, Parexel, PPD, PRA International and Quintiles all received negative marks.
^"S-1". EDGAR. 24 June 2016. Retrieved 2016-06-26.
Medpace Holdings, Inc. (alt. Medpace) is a global clinical research organization (CRO) based in Cincinnati, Ohio, employing approximately 5,400 people...
Parexel ($2.44B revenue in 2017) Wuxi Apptec ($1.01B revenue in 2017) Medpace ($0.92B revenue in 2020) List of pharmaceutical companies Contract manufacturing...
Cinven agreed to purchase this web hosting firm for around $666 million. Medpace – In February 2014, Cinven agreed to acquire the pharmaceutical contract...
February 2014, CCMP sold the pharmaceutical contract research organization Medpace to Cinven for around $900 million. In August 2016, CCMP Capital Advisors...
Multi-Utilities Medical Properties Trust MPW Real Estate Health Care REITs Medpace MEDP Health Care Medtronic MDT Health Care Health Care Equipment Merck...
Global Information
Over 40 countries (2023)[1]